sulfasalazine has been researched along with Berger Disease in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a patient with IgA nephropathy associated with Crohn disease." | 1.31 | An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications. ( Kuwajima, H; Okada, M; Takemura, T; Yagi, K; Yanagida, H, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takemura, T | 1 |
| Okada, M | 1 |
| Yagi, K | 1 |
| Kuwajima, H | 1 |
| Yanagida, H | 1 |
1 other study available for sulfasalazine and Berger Disease
| Article | Year |
|---|---|
An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications.
Topics: Adolescent; Alkylating Agents; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; A | 2002 |